INTERCEPT PHARMACEUTICALS IN shareholders Q3 2023

INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 157 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 2.78 and the average weighting 0.2%.

INTERCEPT PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
HSBC HOLDINGS PLC 456,623$8,484,0550.01%
Jump Financial, LLC 12,930$239,7220.01%
Trexquant Investment LP 16,448$304,9460.01%
Bull Oak Capital, LLC 321$5,9510.01%
Kingsview Wealth Management, LLC 10,100$187,2540.01%
TWO SIGMA ADVISERS, LP 146,200$2,710,5480.01%
ExodusPoint Capital Management, LP 35,087$6510.01%
China Universal Asset Management Co., Ltd. 1,071$200.01%
GAMCO INVESTORS, INC. ET AL 29,950$555,2730.01%
TUDOR INVESTMENT CORP ET AL 25,000$463,5000.01%
Janney Montgomery Scott LLC 68,068$1,2620.01%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 56,353$1,044,7850.01%
ALPS ADVISORS INC 30,878$572,4780.01%
FinTrust Capital Advisors, LLC 1,207$22,3780.01%
GOLDMAN SACHS GROUP INC 1,019,073$18,893,6130.00%
Raymond James Financial Services Advisors, Inc. 116,267$2,155,5940.00%
GUGGENHEIM CAPITAL LLC 22,285$413,1640.00%
TWO SIGMA INVESTMENTS, LP 84,718$1,570,6720.00%
PIN OAK INVESTMENT ADVISORS INC 154$30.00%
GROUP ONE TRADING, L.P. 53,694$995,4870.00%
External links

This page lists INTERCEPT PHARMACEUTICALS IN's shareholders in Q3 2023. To view INTERCEPT PHARMACEUTICALS IN's shareholder history, click here.